Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.
作者信息
Ahmad R A, Rogers H J, Vandenburg M, Wright P
出版信息
Br J Clin Pharmacol. 1981 Jul;12(1):83-6. doi: 10.1111/j.1365-2125.1981.tb01860.x.
Abstract
摘要
相似文献
1
Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation.同时给予N-乙酰转移酶的其他底物对氨苯砜乙酰化的影响。
Br J Clin Pharmacol. 1981 Jul;12(1):83-6. doi: 10.1111/j.1365-2125.1981.tb01860.x.
2
[Pharmacokinetics of drug preparations metabolized by N-acetyltransferase].[经N-乙酰转移酶代谢的药物制剂的药代动力学]
Klin Med (Mosk). 1982 Jan;60(1):24-7.
3
Polymorphic acetylation of drugs in rabbits.家兔体内药物的多态性乙酰化
Xenobiotica. 1973 Mar;3(3):133-50. doi: 10.3109/00498257309151508.
4
5
Ecogenetic studies of drug acetylation in man and rats.人和大鼠药物乙酰化的生态遗传学研究。
Acta Anthropogenet. 1981;5(2):111-8.
6
The polymorphic acetylation of dapsone in man.氨苯砜在人体内的多态性乙酰化作用。
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):225-38. doi: 10.1002/cpt1971122part1225.
7
N-acetylation of drugs: search for INH acetylation polymorphism in baboons.药物的N-乙酰化：狒狒中异烟肼乙酰化多态性的研究
Drug Metab Dispos. 1979 May-Jun;7(3):194-5.
8
Dapsone acetylation in man: another example of polymorphic acetylation.人类中的氨苯砜乙酰化：多态性乙酰化的另一个例子。
Ann N Y Acad Sci. 1971 Jul 6;179:660-6. doi: 10.1111/j.1749-6632.1971.tb46942.x.
9
Disease and acetylation polymorphism.疾病与乙酰化多态性
Clin Pharmacokinet. 1977 May-Jun;2(3):182-97. doi: 10.2165/00003088-197702030-00003.
10
Dapsone acetylation by human liver arylamine N-acetyltransferases and interaction with antiopportunistic infection drugs.
Drug Metab Dispos. 1995 Apr;23(4):473-7.
引用本文的文献
1
Investigation of -Acetyltransferase 2-Mediated Drug Interactions of Amifampridine: In Vitro and In Vivo Evidence of Drug Interactions with Acetaminophen.阿米芬啶的N-乙酰转移酶2介导的药物相互作用研究：与对乙酰氨基酚药物相互作用的体外和体内证据
Pharmaceutics. 2023 May 11;15(5):1471. doi: 10.3390/pharmaceutics15051471.
2
The effects of acute ethanol intake on isoniazid pharmacokinetics.急性乙醇摄入对异烟肼药代动力学的影响。
Eur J Clin Pharmacol. 2004 Nov;60(9):679-82. doi: 10.1007/s00228-004-0828-y. Epub 2004 Oct 2.
3
Interaction of ibuprofen and probenecid with drug metabolizing enzyme phenotyping procedures using caffeine as the probe drug.以咖啡因作为探针药物，布洛芬和丙磺舒与药物代谢酶表型分析程序的相互作用。
Br J Clin Pharmacol. 2003 Feb;55(2):191-8. doi: 10.1046/j.1365-2125.2003.01725.x.
4
A simple method for determining acetylator phenotype using isoniazid.一种使用异烟肼测定乙酰化酶表型的简单方法。
Br J Clin Pharmacol. 1986 Sep;22(3):343-5. doi: 10.1111/j.1365-2125.1986.tb02897.x.
5
Clinical pharmacokinetics of dapsone.氨苯砜的临床药代动力学
Clin Pharmacokinet. 1986 Jul-Aug;11(4):299-315. doi: 10.2165/00003088-198611040-00003.
6
Genetically determined variability in acetylation and oxidation. Therapeutic implications.乙酰化和氧化的基因决定变异性。治疗意义。
Drugs. 1985 Apr;29(4):342-75. doi: 10.2165/00003495-198529040-00003.
本文引用的文献
1
THE METABOLISM OF 1-HYDRAZINOPHTHALAZINE.1-肼基酞嗪的代谢
J Pharmacol Exp Ther. 1964 Jan;143:7-13.
2
Kinetic characteristics of the acetylation of isoniazid and p-aminosalicylic acid by a liver-enzyme preparation.肝酶制剂对异烟肼和对氨基水杨酸乙酰化作用的动力学特征
Biochim Biophys Acta. 1962 Nov 19;65:121-7. doi: 10.1016/0006-3002(62)90155-5.
3
The inhibition of isoniazid inactivation by means of PAS and benzoyl-PAS in man.对氨基水杨酸（PAS）和苯甲酰对氨基水杨酸（benzoyl-PAS）对人体异烟肼失活的抑制作用。
Am Rev Respir Dis. 1959 Jul;80(1, Part 1):26-37. doi: 10.1164/arrd.1959.80.1P1.26.
4
Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method.
Eur J Clin Pharmacol. 1980 Feb;17(2):129-33. doi: 10.1007/BF00562621.
5
The polymorphic acetylation of dapsone in man.氨苯砜在人体内的多态性乙酰化作用。
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):225-38. doi: 10.1002/cpt1971122part1225.
6
An improved and simplified method of detecting the acetylator phenotype.一种检测乙酰化酶表型的改良简化方法。
J Med Genet. 1969 Dec;6(4):405-7. doi: 10.1136/jmg.6.4.405.
7
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.多种N-乙酰基转移酶与药物代谢。哺乳动物N-乙酰基转移酶的组织分布、特性及意义。
Biochem J. 1973 Mar;132(3):519-26. doi: 10.1042/bj1320519.
8
Elimination rate of N-acetylprocainamide after a single intravenous dose of procainamide hydrochloride in man.单次静脉注射盐酸普鲁卡因胺后人体中N-乙酰普鲁卡因胺的消除率。
J Pharmacokinet Biopharm. 1975 Apr;3(2):69-76. doi: 10.1007/BF01066016.
9
Pharmacokinetics of isoniazid metabolism in man.
J Pharmacokinet Biopharm. 1976 Apr;4(2):83-113. doi: 10.1007/BF01086149.
10
Kinetics of hydralazine elimination.
Clin Pharmacol Ther. 1977 Jun;21(6):715-20. doi: 10.1002/cpt1977216715.
Zotero 插件